To extend the role of CD105 in ovarian cancer metastasis to high-grade serous ovarian cancer cells, we introduced shRNA (shCD105-1and-2) to OVCAR3, an HGSC cell line that is 100% CD105(+) by FACS analysis. This evidence concerns the gene ENG and ovarian serous adenocarcinoma.